0001209191-23-021260.txt : 20230327
0001209191-23-021260.hdr.sgml : 20230327
20230327172843
ACCESSION NUMBER: 0001209191-23-021260
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230323
FILED AS OF DATE: 20230327
DATE AS OF CHANGE: 20230327
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Calabrese Salvatore
CENTRAL INDEX KEY: 0001851958
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40237
FILM NUMBER: 23765539
MAIL ADDRESS:
STREET 1: C/O GAIN THERAPEUTICS, INC.
STREET 2: 4800 HAMPDEN LANE, SUITE 200
CITY: BETHESDA
STATE: MD
ZIP: 20814
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Gain Therapeutics, Inc.
CENTRAL INDEX KEY: 0001819411
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851726310
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4800 HAMPDEN LANE
STREET 2: SUITE 200
CITY: BETHESDA
STATE: MD
ZIP: 20814
BUSINESS PHONE: (301) 500-1556
MAIL ADDRESS:
STREET 1: 4800 HAMPDEN LANE
STREET 2: SUITE 200
CITY: BETHESDA
STATE: MD
ZIP: 20814
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-03-23
0
0001819411
Gain Therapeutics, Inc.
GANX
0001851958
Calabrese Salvatore
C/O GAIN THERAPEUTICS, INC.
4800 MONTGOMERY LANE, SUITE 220
BETHESDA
MD
20814
0
1
0
0
Chief Financial Officer
0
Employee Stock Option (right to buy)
4.84
2023-03-23
4
A
0
50000
0.00
A
2033-03-23
Common Stock
50000
50000
D
Restricted Stock Units
2023-03-23
4
A
0
25000
0.00
A
Common Stock
25000
25000
D
The shares underlying the option shall vest 25% on March 23, 2024 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.
Each restricted stock unit ("RSU") represents a contingent right to receive one share of Issuer common stock.
The RSUs shall vest 25% on March 23, 2024 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.
/s/ Jason Minio, Attorney-in-Fact
2023-03-27